跳至主要内容
临床试验/ACTRN12605000594628
ACTRN12605000594628招募中不适用

A pilot study to evaluate the feasibility, safety and efficacy of psychotherapeutic intervention for comorbid BPD and first-episode psychosis

Orygen Research Centre and Orygen Youth Health0 个研究点目标入组 16 人开始时间: 2005年10月5日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
16

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
15 Years 至 25 Years(—)
性别
All

入选标准

  • (1) Eligibility for EPPIC program, 1 week or more of psychotic symptoms with less than 6 months of active previous treatment (i.e., antipsychotic medication); and (2) Diagnosis of four or more DSM-IV BPD traits (APA, 1994).

排除标准

  • (1) Severe and enduring psychotic symptoms, defined as scores of 4 or more on 1 or more psychotic items of the Brief Psychiatric Rating Scale (BPRS) which have persisted for more than 1 month (Overall & Gorham, 1962); (2)Unable to converse in, or read English without an interpreter; (3) Intellectual deficits, such that unable to meaningfully participate in the psychotherapy; and (4) Already given informed consent for another psychotherapy trial at ORYGEN Youth Health, or already received a course of CAT.

研究者

发起方
Orygen Research Centre and Orygen Youth Health

相似试验

A pilot study of psychotherapeutic intervention for... | 临床试验